Why the study?
Autonomic dysfunction in hypertension increases cardiovascular risk, and heart rate variability serves as a method to assess cardiac autonomic modulation across different hypertensive syndromes.
This review highlights the potential of heart rate variability as a clinical tool to estimate individual cardiovascular risk across different stages and types of hypertension.
No takes yet. Share an insight, caveat, or question.
May support ANS assessment in HTN diagnostics; leaves open therapeutic implications pending higher-level evidence.
Yugar et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: